Investor Relations (IR) Questions: ImmunoCellular Therapeutics IMUC
Click here to return to the biotech IRQ Index
Answers received: February 2013
1) When is the last time IMUC raised cash through an offering (diluted)?
The company raised about $20 million in October of last year.
2) How much cash (not cash equivalents) does IMUC have?
The company reported cash of about $10 million on the most recent 10Q, which was prior to the raise in October.
3) What and approximately when is the next known catalyst?
The next catalyst could be an interim analysis for the ongoing Phase 2b study, which might occur as early as this quarter.
4) What is IMUC's quarterly cash burn?
The burn rate is about $3 million per quarter.
5) Does IMUC have an existing line of credit and if so how much can they draw against it?
(no response)
1) When is the last time IMUC raised cash through an offering (diluted)?
The company raised about $20 million in October of last year.
2) How much cash (not cash equivalents) does IMUC have?
The company reported cash of about $10 million on the most recent 10Q, which was prior to the raise in October.
3) What and approximately when is the next known catalyst?
The next catalyst could be an interim analysis for the ongoing Phase 2b study, which might occur as early as this quarter.
4) What is IMUC's quarterly cash burn?
The burn rate is about $3 million per quarter.
5) Does IMUC have an existing line of credit and if so how much can they draw against it?
(no response)